Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1992-3-30
|
pubmed:abstractText |
CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy camptothecin, is a newly developed water-soluble camptothecin derivative now undergoing phase-II evaluation. In an attempt to establish whether the combination of CPT-11 with other standard anti-cancer agents would be of any benefit, we studied the effects of CPT-11 in combination with 11 other anti-cancer agents on a human T-cell leukemia cell line, MOLT-3, in culture. We used both CPT-11 and SN-38 (active substance of CPT-11 in vivo), for our study. Cells were incubated for 3 days in the presence of 2 drugs (CPT-11 or SN-38 and another drug) and cytotoxic effects were determined by MTT assay. The effects of drug combinations on ID50 were analyzed by an improved isobologram method. Supra-additive and marginal supra-additive effects (synergism) were observed for CPT-11 in combination with cisplatin, cytosine arabinoside and mitomycin C. Additive effects were observed for its combination with amsacrine, bleomycin, doxorubicin, etoposide, 5-fluorouracil, mitoxantrone and vincristine. Alternate sub-additive and protective effects (antagonism) were observed for CPT-11 in combination with methotrexate. Similar tendencies were observed for SN-38 in combination with other agents. These results suggest that CPT-11 in simultaneous administration with a majority of anti-cancer agents has an advantage for cytokilling. Of these agents, cisplatin, cytosine arabinoside and mitomycin C are most suitable for simultaneous administration with CPT-11.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
604-10
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1537625-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:1537625-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1537625-Camptothecin,
pubmed-meshheading:1537625-Cell Death,
pubmed-meshheading:1537625-Cell Division,
pubmed-meshheading:1537625-Dose-Response Relationship, Drug,
pubmed-meshheading:1537625-Drug Synergism,
pubmed-meshheading:1537625-Humans,
pubmed-meshheading:1537625-Leukemia, Lymphoid,
pubmed-meshheading:1537625-Tumor Cells, Cultured
|
pubmed:year |
1992
|
pubmed:articleTitle |
Effects of CPT-11 in combination with other anti-cancer agents in culture.
|
pubmed:affiliation |
Division of Medical Oncology, Tochigi Cancer Center, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro
|